News
Objective To evaluate the cost-effectiveness of polatuzumab vedotin–rituximab–cyclophosphamide, doxorubicin and prednisone (pola-R-CHP) in CD20-positive patients with previously untreated diffuse ...
Sundaram Finance Ltd, the Chennai-based non-banking financial company, is revising deposit interest rates effective July 1, 2025. This is in line with RBI’s repo rate revision announced recently.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results